Aprea Therapeutics, Inc. (APRE) has 20 known insider and institutional holders on record. The largest holder is KDev Investments AB with 1,992,586 shares. Other notable holders include Redmile Group, LLC and 5AM Ventures IV, L.P..
Over the last 12 months, insiders have made 17 transactions in APRE stock — 17 buys (valued at $282.09K) and 0 sells (valued at RSU Award). Insider buying has outpaced selling during this period, which may signal confidence in the company's prospects.
APRE Insider Ownership
Top Holder
KDev Investments AB
1,992,586 shares
Buys (12 mo)
17
$282.09K value
Sells (12 mo)
0
$0.00 value
12-Month Transaction Activity
Top Insider Holders
| # |
Name |
Role |
Shares Owned |
Last Filed |
Relative Size |
| 1 |
Kdev Investments Ab |
10 Percent Owner |
1,992,586 |
2020-07-07 |
|
| 2 |
Redmile Group, Llc |
10 Percent Owner |
1,768,718 |
2021-02-16 |
|
| 3 |
5am Ventures Iv, L.p. |
Other: Former 10% Holder |
138,497 |
2020-10-07 |
|
| 4 |
Peters Richard |
Director |
123,915 |
2026-04-01 |
|
| 5 |
Coiante Scott M |
SVP, Chief Financial Officer |
89,200 |
2022-08-01 |
|
| 6 |
Gilad Oren |
President/ceo |
80,700 |
2026-03-16 |
|
| 7 |
Versant V Luxco S.a R.l. |
10 Percent Owner |
66,506 |
2020-05-20 |
|
| 8 |
Schade Christian S |
Director |
47,600 |
2022-08-01 |
|
| 9 |
Abrahmsen Lars B. |
SVP, Chief Scientific Officer |
43,700 |
2022-03-14 |
|
| 10 |
Korbel Gregory Alan |
SVP, Chief Operating Officer |
35,700 |
2022-08-01 |
|
| 11 |
Hamill John P. |
Srvp/cfo/prin Fin & Acct Ofcr |
30,978 |
2026-04-01 |
|
| 12 |
Duey Marc |
Director |
21,459 |
2025-12-11 |
|
| 13 |
Mirza Nadeem Q. |
Chief Medical Officer |
6,730 |
2024-05-02 |
|
| 14 |
Magni Guido |
Director |
6,500 |
2019-10-07 |
|
| 15 |
Rocklage Scott M |
Director |
5,600 |
2020-07-01 |
|
| 16 |
Hepple Jonathan |
Director |
5,600 |
2020-07-01 |
|
| 17 |
Namouni Fouad |
Director |
4,610 |
2021-07-01 |
|
| 18 |
Henneman John B Iii |
Director |
4,185 |
2025-06-09 |
|
| 19 |
Pamukcu Rifat |
Director |
4,185 |
2025-06-09 |
|
| 20 |
Seizinger Bernd R. |
Director |
4,185 |
2025-06-09 |
|
Recent Transactions (last 12 months)
| Date |
Name |
Role |
Type |
Shares |
Price |
Value |
| 2026-03-31 |
Hamill John P. |
Srvp/cfo/prin Fin & Acct Ofcr |
Informative Buy |
30,978 |
$0.68 |
$21.16K |
| 2026-03-31 |
Peters Richard |
Director |
Informative Buy |
123,915 |
$0.68 |
$84.63K |
| 2026-03-12 |
Gilad Oren |
President/ceo |
RSU Award |
80,700 |
$0.77 |
$61.74K |
| 2026-03-12 |
Hamill John P. |
Srvp/cfo/prin Fin & Acct Ofcr |
RSU Award |
40,380 |
$0.77 |
$30.89K |
| 2026-01-30 |
Gilad Oren |
President/ceo |
Informative Buy |
28,100 |
$0.77 |
$21.5K |
| 2026-01-30 |
Hamill John P. |
Srvp/cfo/prin Fin & Acct Ofcr |
Informative Buy |
5,700 |
$0.77 |
$4.36K |
| 2025-12-10 |
Gilad Oren |
President/ceo |
Informative Buy |
21,459 |
$0.00 |
$2.15 |
| 2025-12-10 |
Duey Marc |
Director |
Informative Buy |
21,459 |
$1.04 |
$22.32K |
| 2025-12-10 |
Hamill John P. |
Srvp/cfo/prin Fin & Acct Ofcr |
Informative Buy |
5,000 |
$1.04 |
$5.2K |
| 2025-06-05 |
Pamukcu Rifat |
Director |
RSU Award |
4,185 |
$1.81 |
$7.57K |
| 2025-06-05 |
Duey Marc |
Director |
RSU Award |
4,185 |
$1.81 |
$7.57K |
| 2025-06-05 |
Gruia Gabriela |
Director |
RSU Award |
1,045 |
- |
- |
| 2025-06-05 |
Seizinger Bernd R. |
Director |
RSU Award |
4,185 |
$1.81 |
$7.57K |
| 2025-06-05 |
Grissinger Michael |
Director |
RSU Award |
1,045 |
- |
- |
| 2025-06-05 |
Peters Richard |
Director |
RSU Award |
1,045 |
- |
- |
| 2025-06-05 |
Bizzari Jean-pierre |
Director |
RSU Award |
1,045 |
- |
- |
| 2025-06-05 |
Henneman John B Iii |
Director |
RSU Award |
4,185 |
$1.81 |
$7.57K |
